Latest filing published 29 Apr 2026 for Medtronic plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Lidia Fonseca (chief executive) discloses dealings in 3 companies, chiefly Medtronic plc, Pfizer Inc and Tegna Inc. In total, 11 filings cover trades dated from 1 May 2021 to 28 April 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 29 April 2026, the filings show a share grant worth €14k in Medtronic plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations